Skip to content
Boston Collaborative Drug Surveillance Program (BCDSP)
  • Home
  • Services
  • Research
  • Our Team
  • History
  • Publications

Rheumatology (Oxford)

  • Home
  • Rheumatology (Oxford)

The risks of major cardiac events among patients with psoriatic arthritis treated with apremilast, biologics, DMARDs or corticosteroids

Posted by By BCDSP November 7, 2020Posted inUncategorized
Journal: Rheumatology (Oxford) Authors: Rebecca Persson, Katrina Wilcox Hagberg, Yiran Qian, Catherine Vasilakis-Scaramozza, Susan Jick NLM Citation: Persson R, Hagberg KW, Qian Y, Vasilakis-Scaramozza C, Jick S. The risks of major cardiac events among…
Read More

A cohort study of comorbidity in patients with granulomatosis with polyangiitis

Posted by By BCDSP February 1, 2018Posted inDisease Epidemiology Studies, Rare and understudied diseases, Select Publications
Journal: Rheumatology (Oxford) Authors: Lin Li, Tuhina Neogi, Susan Jick NLM Citation: Li L, Neogi T, Jick S. A cohort study of comorbidity in patients with granulomatosis with polyangiitis. Rheumatology (Oxford).…
Read More

Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink

Posted by By BCDSP May 1, 2017Posted inDisease Epidemiology Studies, Rare and understudied diseases, Select Publications
Journal: Rheumatology (Oxford) Authors: Lin Li, Tuhina Neogi, Susan Jick NLM Citation: Li L, Neogi T, Jick S. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK…
Read More
  • @BCDSP_DRG on Twitter
  • BCDSP on LinkedIn
  • @bcdsp.bsky.social‬ on BlueSky
Boston Collaborative Drug Surveillance Program (BCDSP)

55 Waltham Street, Rear | Lexington, MA 02421 USA
Phone: +1 (781) 862-6660
E-mail: info@bcdsp.org

Copyright 2026 — Boston Collaborative Drug Surveillance Program (BCDSP). All rights reserved.
Scroll to Top